Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease

Journal of Pain and Symptom Management

Volumn 19, Issue 1, 2000, Pages 63-72

  Beyer, Judith E ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

And analgesics; Children; Comfort; Pain; Sickle cell disease

Indexed keywords

NALBUPHINE;

ADOLESCENT; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; SCHOOL CHILD; SICKLE CELL ANEMIA; VEIN OCCLUSION;

ADOLESCENT; ANALGESIA; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; CHILD; FEMALE; HUMANS; INTERVIEWS; MALE; NALBUPHINE; PAIN; VASCULAR DISEASES;

EID: 0033969576     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00134-7     Document Type: Article

References (37)

1. Shapiro B. The management of pain in sickle cell disease. Pediatr Clin North Am 1989;36:1029-1045.
2. Burghart-Fitzgerald DD. Pain behavior contracts: Effective management of the adolescent in sickle cell crisis. J Pediatr Nurs 1989;4:320-324.
3. Houser B, Plawecki HM, Carr J, Smith MA, Plawecki JA. A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease. J Holistic Nurs 1994;10:62-75.
4. Morrison R, Vedro D. Pain management in the child with sickle cell disease. Pediatr Nurs 1989;15:595-600.
5. Schechter NL, Berrien FB, Katz SM. The use of patient-controlled analgesia in adolescents with sickle cell pain crisis: A preliminary report. J Pain Symptom Manage 1988;3:109-113.
6. Shapiro B. Treating the pain of sickle-cell disease. APS Bulletin 1992;Jan/Feb:9-11.
7. Shapiro BS, Schechter NL, Ohene-Frempong K, Eds. The Genetic Resource, Sickle Cell Disease-Related Pain: Assessment and Management. Mt. Desert, ME: New England Regional Genetics Group, 1994.
8. Vichinsky E, Lubin BH. Hematol/Oncol Clin North Am 1987;1:483-501.
9. Schechter NL. The undertreatment of pain in children: An overview. Pediatr Clin North Am 1989;36:781-794.
10. Schechter NL, Allen D. Physicians' attitudes toward pain in children. Devel Behav Pediatr 1986;7:350-354.
11. Schechter NL, Berde CB, Yaster M. Pain in infants, children, and adolescents: An overview. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents. Baltimore: Williams & Wilkins, 1993.
12. Trentadue NO, Kachoyeanos MK, Lea G. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease. J Pediatr Nurs 1998;13:15-19.
13. Shapiro BS, Cohen DE, Howe CJ. Patient-controlled analgesia for sickle-cell- related pain. J Pain Symptom Manage 1993;8:22-27.
14. Sartori PC, Gordon GJ, Darbyshire PJ. Continuous papaveretum infusion for the control of pain in painful sickling crisis. Arch Dis Child 1990;65:1151-1153.
15. Dampier CD, Setty BNY, Logan J, Ioli JG, Dean R. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatrics 1995;126:462-467.
16. Yaster M, Tobin JR, Billett C, Casella JF, Dover G. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Pediatrics 1994;93:310-315.
17. Woods GM, Parson PM, Strickland DK. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease. J Assoc Academic Minority Physicians 1992;3:90-92.
18. Turner E, Shapiro B. Pharmacological management of pain. In: Shapiro B, Schechter N, Ohene-Frempong K, eds. The Genetic Resource, Sickle Cell Disease-Related Pain: Assessment and Management. Mt. Desert, ME: New England Regional Genetics Group, 1994.
19. Grisham JE, Vichinsky EP. Ketorolac versus meperidine in vaso-occlusive crisis: A study of safety and efficacy. Int J Pediatr Hematol/Oncol 1996;3:239-247.
20. Jacobson SJ, Kopechy EA, Joshi P, Babul N. Randomised trial of morphine for painful episodes of sickle cell disease in children. Lancet 1997;350:1359-1361.
21. Robieux IC, Kellner JD, Coppes MJ, Shaw D, Brown E, Good C, Manson D, Olivieri NF, Zipursky A, Gideon K. Analgesia in children with sickle cell crisis: Comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebocontrolled study of oxygen inhalation. Pediatr Hematol Oncol 1992;9:317-326.
22. Griffin TC, McIntire D, Buchanan GR. Highdose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 1994;330:733-737.
23. Beyer JE, Knott C. Construct validity estimation for the African-American and Hispanic Oucher scale. J Pediatr Nurs 1998;13:20-31.
24. Villarruel A, Denyes M. Pain assessment in children: Theoretical and empirical validity. Adv Nurs Sci 1991;14:32-41.
25. Grossi E, Borghi C, Cerchiara E, Della Puppa T, Francucci B. Analogue chromatic continuous scale: A new method for pain assessment. Clin Exper Rheumatol 1983;1:337-340.
26. Grossi E, Borghi C, Montanari M. Measurement of pain: Comparison between visual analog scale and analog chromatic continuous scale. In: Fields HL, ed. Advances in Pain Research and Therapy, Vol 9. New York: Raven Press, 1985:371-376.
27. Grossi E, Fantini F, Gerloni V, Murelli M. Analogue chromatic continuous scale: A new method for pain assessment in children with rheumatoid arthritis. Presented at the First Workshop on Disease Evaluation for Therapeutic Protocols in Children, Milan, Italy, Feb. 28, 1985.
28. Savedra M, Tesler M, Holzemer W, Wilkie D, Ward J. Testing a tool to assess postoperative pediatric and adolescent pain. In: Tyler DC, Krane EJ, eds. Advances in Pain Research and Therapy, Vol 15. New York: Raven Press, 1990:85-94.
29. Tesler M, Savedra M, Holzemer W, Wilkie D, Ward J, Paul S. The word-graphic rating scale as a measure of children and adolescents' pain intensity. Res Nursing Health 1991;14:361-371.
30. U.S. Department of Health and Human Services. Acute Pain Management: Operative or Medical Procedures and Trauma. Bethesda: Agency for Health Care Policy and Research, 1992.
31. Shapiro BS. Management of painful episodes in sickle cell disease. In: Schechter N, Berde C, Yaster M, eds. Textbook of Pediatric Pain. Baltimore: Williams & Wilkins, 1993:385-409.
32. Walco GA, Erickson CJ, Eckman J. Non-pharmacologic management of pain. In: Shapiro BS, Schechter NL, Ohene-Frempong K, eds. The Genetic Resource, Sickle Cell Disease Related Pain: Assessment and Management. Mt. Desert, ME: New England Regional Genetics Group, 1994.
33. Beyer J, Simmons L, Woods G, Woods P. Caregivers' Views on Pain and Comfort for Children and Adolescents with Sickle Cell Disease, Part I: Home Comfort Measures. Submitted.
34. Beyer J, Simmons L, Woods G, Woods P. Caregivers' Views on Pain and Comfort for Children and Adolescents with Sickle Cell Disease, Part II: Hospital Comfort Measures. Submitted.
35. Beyer J, Simmons L, Woods G, Woods P. A chronology of pain/comfort in children with sickle cell disease. Arch Pediatr Adolesc Med 1999;153:913-920.
36. Sporrer KA, Jackson SM, Agner S, Laver J, Abboud MR. Pain in children and adolescents with sickle cell anemia: A prospective study utilizing self-reporting. Am J Pediatr Hematol/Oncol 1994;16:219-224.
37. American Pain Society. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. Glenview, IL: American Pain Society, November 1999.